ABSTRACT
Objective:To explore the effects of Bailing capsules combined with salvianolate on inflammatory cytokines, renal vas-cular endothelia and renal function in diabetic nephropathy inⅣphase. Methods:Totally 60 patients with diabetic nephropathy in IV phase were randomly divided into the control group (30 cases) and the treatment group (30 cases). The control group was given the conventional and salvianolate therapy, and the treatment group was treated with Bailing capsules additionally. The treatment course was 3 months. The changes of serum creatine(SCr), urean itrogen (BUN), creatinine clearance rate (Ccr), ethelin (ET-1), interleukin-6 (IL-6), tumor necrosis factor (TNF-a) and C-reactive protein (CRP) were detected before and after the treatment. Results:After the 3-month treatment, SCr, BUN, IL-6, TNF-a, CRP and ET-1 were significantly decreased in the two groups with statistical signifi-cance, and Ccr was significantly increased in the treatment group (P0. 05). There was no significant difference in the incidence of adverse drug reactions between the two groups (P>0. 05). Conclusion:The combination of Bailing capsules and salvianolate can re-duce the inflammatory reaction and improve renal vascular endothelial function and renal function in the patients with diabetic nephrop-athy in Ⅳ phase with promising safety and few adverse reactions.
ABSTRACT
Objective:To explore the therapeutic effect on blood glucose, lipid, and renal function of Bailing capsules combined with calcium dobesilate dispersible tablets in the treatment of diabetic nephropathy. Methods: Totally 216 patients with diabetic ne-phropathy in phase Ⅳ were randomly divided into the control group (108 cases) and the treatment group (108 cases). The control group was given the conventional therapy, and the treatment group was treated with Bailing capsules combined with calcium dobesilate dispersible tablets additionally. The levels of serum creatine (Scr), urean ntrogen (BUN), endothelin (ET-1), β2-microglobulin (β2-MG) ,cystatin C ( CYC) and urinary albumin excretion rate ( UAER) were detected for all the patients before and after the treat-ment. The adverse drug reactions were observed as well. Results:After the treatment, all the indices in the two groups were all obvi-ously decreased (P0. 05). The adverse drug reactions showed no significant differences between the two groups (P>0. 05). Conclusion:The effect of Bailing capsules combined with calcium dobesilate dispersible tablets is better than that of calcium dobesilate dispersible tablets in the treatment of diabetic nephropathy in phase IV, which can improve the renal function indices with high safety and without notable influence on blood glucose and lipid.
ABSTRACT
ObjectiveTo explore the relationship of circadian distribution of acute myocardial infarction with AMI location and ST segment changes in elderly patients.MethodsThe time of infarction, its anatomic location, changes of ST segment, and coronary angiography were studied in 909 elderly patients with acute myocardial infarction (AMI) ( 412 with anterior AMI and 423 with inferior AMI) admitted to our coronary care units from January 1996 to January 2006.ResultsThe onset of inferior myocardial infarction were more frequent between midnight and 6AM than other periods of the day (n=138/423,32.6% of all inferior myocardial infarction patients, P<0.01). The onset of anterior myocardial infarction were more frequent between 6AM and noon than other periods of the day (n=156/412, 37.9% of all anterior myocardial infarction patients, P<0.01). Coronary angiography was performed in 789 patients (86.8%, 516/909).118 cases of them with inferior infarction occured between midnight and 6AM, including 85.6% of them were due to right coronary artery occlusion and 14.0%(17/118) of them were due to left coronary artery occlusion (P<0.01).275 cases of them with inferior infarction oecured between 6AM and midnight, including 52.2% (149/275) of them were due to right coronary artery occlusion and 45.8% of them were due to left coronary artery occlusion (P>0. 05). The onset of inferior myocardial infarction between 6AM and noon was the most frenquent in patients with ST segment elevation (44.0%, 263/644), while the onset of inferior myocardial infarction between midnight and 6 AM was the most frenquent in patients with non-ST segment elevation (36.6%,96/265). ConclusionsThe frequency of AMI at night is higher in elderly patients with ST segment elevation than in elderly patients with non-ST segment elevation.AMI at night is usually due to right coronary artery occlusion, which suggests that a protective role of sleep may be limited to left coronary artery -related events and AMI of non-ST segment.
ABSTRACT
Objective To investigate the difference of the morbidity rate of hypertension among patients with sleep apnea syndrome (SAS) in different stages, and the change in the blood levels of some vasoactive substances and their correlations with severity of SAS, in order to further explore the mechanism of hypertension caused by SAS. Methods 63 patients suspected to suffer from SAS were enrolled, and they were divided into normal, mild, moderate, and severe SAS groups according to respiratory disorder index (RDI) obtained by polysomnography (PSG) monitoring. The diagnosis of hypertension was made by the measurement of blood pressure and 24-hour dynamic measurement of blood pressure. Blood levels of angiotesnin Ⅱ (Ang Ⅱ), endothelin-1 (ET-1), throboxane B2 (TXB2), calcium gene related protein (CGRP), 6-keto-protagladin factor1?(6-keto-PGF1?) were determined with radioimmunoassay. Results The mobidity rate of hypertension was significantly higher in moderate and severe SAS group than that in the normal group (P0.05). Correlative analysis showed that the blood levels of Ang Ⅱ, ET-1, TXB2 were positively correlative to RDI (r=0.594, 0.523, 0.574, respectively, P0.05). Conclusion SAS is significantly related to the incidence of hypertension. Vasoactive substances with vasoconstrictive effect such as Ang Ⅱ, ET-1, TXB2 play an important role in the pathogenesis and development of hypertension in SAS patients than those with vasodilative effect such as CGRP and 6-keto-PGF1?.